Related Experiment Videos
Increased expression of the multidrug-resistance gene in undifferentiated sarcoma
1Department of Pediatrics, Osaka University Medical School, Japan.
Abstract:
We analyzed multidrug-resistance gene (mdr1 gene) expression in a patient with undifferentiated sarcoma of the liver using the cloned cDNA for the mdr1 gene. Tissue samples were available at the time of initial diagnosis and of two intracranial relapses after chemotherapy with a regimen including doxorubicin and teniposide. The level of mdr1 gene expression was increased sevenfold in the intracranial tumor at the time of first relapse and 11-fold at the second relapse. This case may be an example of acquired multidrug resistance associated with overexpression of the mdr1 gene.
Insights
Multidrug-resistance gene (mdr1 gene) expression increased significantly in liver sarcoma relapses after chemotherapy. This suggests acquired multidrug resistance may be linked to mdr1 gene overexpression.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Understanding mechanisms of acquired multidrug resistance (MDR) in cancers is crucial for effective treatment.
- The multidrug-resistance gene (mdr1 gene) is implicated in cellular resistance to various chemotherapeutic agents.
Observation:
- This study analyzed mdr1 gene expression in a patient with undifferentiated liver sarcoma.
- Tissue samples were collected at initial diagnosis and during two intracranial relapses post-chemotherapy (doxorubicin, teniposide).
Findings:
- mdr1 gene expression showed a sevenfold increase at the first intracranial relapse.
- A further 11-fold increase in mdr1 gene expression was observed at the second intracranial relapse.
Implications:
- This case provides evidence for acquired multidrug resistance potentially driven by mdr1 gene overexpression in liver sarcoma.
- Findings highlight the importance of monitoring mdr1 gene expression in relapsed cancers.
- Further research into mdr1 gene's role in chemotherapy resistance is warranted.